Altomiv Tablets 10/40 mg
Atorvastatin Calcium Trihydrate 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Seoheung Co., Ltd.
MFDS item code 202101595 · Approved 2021.02.18
This product's status changed to Approval withdrawn on 2025.06.23. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This medicine helps to lower elevated total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol levels, and raises HDL cholesterol levels in patients with primary hypercholesterolemia and mixed dyslipidemia. It can be used alone or in conjunction with other treatments for patients with homozygous familial hypercholesterolemia. This medicine helps reduce the risk of atherosclerotic vascular disease in dyslipidemia patients and is most effective when combined with proper dietary management. Additionally, it is essential to check for other health conditions or medications that may affect hypercholesterolemia before use, and to monitor treatment effects with regular lipid tests. Rapid assessment of lipid levels is recommended when experiencing acute coronary events. Overall, this medicine serves as an important adjunct in the treatment of dyslipidemia.
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response to treatment. Primary hypercholesterolemia The dosage range for this medicine is 10/10 mg to 10/80 mg once daily. The recommended initial dose is 10/10 mg or 10/20 mg once daily. For patients who require a greater reduction in LDL cholesterol (55% or more), the recommended initial dose is 10/40 mg once daily. After starting this medicine or adjusting the dose, blood lipid levels should be checked at intervals of at least 2 weeks, and the dose adjusted accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg or 10/80 mg once daily. This medicine is administered as an adjunct to other lipid-lowering therapy (e.g., LDL-Apheresis), or when other lipid-lowering therapies are not useful.
This medicine may occasionally cause side effects affecting muscles, so if symptoms of muscle pain or weakness occur, it is important to consult a physician immediately. Patients at high risk for severe myopathy or rhabdomyolysis may need to temporarily discontinue or stop this medication. It should not be taken by individuals with allergies to the ingredients or active liver disease, and those with muscle disease are also contraindicated. Pregnant or potentially pregnant women, as well as breastfeeding women, should not take this medication. Patients with liver function problems or a history of severe liver disease should use this medication cautiously and have liver enzyme levels monitored regularly. This medicine may interact with other drugs, especially when taken with medications metabolized in the liver or those affecting muscles. Elderly patients or those with impaired kidney function may also have an increased risk of muscle-related side effects, necessitating physician guidance on usage. Unusual symptoms such as dizziness, muscle pain, or abdominal pain should be reported to healthcare professionals immediately. It is crucial to ensure safety through regular blood tests and liver function tests while on this medication. Caution is advised while driving or operating machinery due to potential dizziness. In the case of overdose, there are no specific antidotes, so appropriate treatment and supportive care should be administered according to symptoms.
Not everyone experiences these, and they can vary from person to person.
This medicine must be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 to 30 degrees Celsius.
White, oblong, film-coated tablet
30 tablets/Alu-Alu[((10 tablets/Alu-Alu) x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Trihydrate 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Seoheung Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.